|
Q3 FY2016
As of Mar 31, 2016
|
Q2 FY2016
As of Dec 31, 2015
|
Q1 FY2016
As of Sep 30, 2015
|
Q4 FY2015
As of Jun 30, 2015
|
Q3 FY2015
As of Mar 31, 2015
|
Q2 FY2015
As of Dec 31, 2014
|
Q1 FY2015
As of Sep 30, 2014
|
Q4 FY2014
As of Jun 30, 2014
|
Q3 FY2014
As of Mar 31, 2014
|
Q2 FY2014
As of Dec 31, 2013
|
Q1 FY2014
As of Sep 30, 2013
|
Q4 FY2013
As of Jun 30, 2013
|
Q3 FY2013
As of Mar 31, 2013
|
Q2 FY2013
As of Dec 31, 2012
|
Q1 FY2013
As of Sep 30, 2012
|
Q4 FY2012
As of Jun 30, 2012
|
Q3 FY2012
As of Mar 31, 2012
|
Q2 FY2012
As of Dec 31, 2011
|
Q1 FY2012
As of Sep 30, 2011
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||||
| Investment securities available for sale | |||||||||||||||||||
| Held-to-maturity Securities, Debt Maturities, Net Carrying Amount | |||||||||||||||||||
| Investment securities held to maturity | |||||||||||||||||||
| Correspondent bank stock | |||||||||||||||||||
| Loans held for sale | |||||||||||||||||||
| Loans and leases receivable | |||||||||||||||||||
| Allowance for loan and lease losses | |||||||||||||||||||
| Loans and leases receivable, net | |||||||||||||||||||
| Accrued interest receivable | |||||||||||||||||||
| Office properties and equipment, net of accumulated depreciation | |||||||||||||||||||
| Foreclosed real estate and other properties | |||||||||||||||||||
| Cash value of life insurance | |||||||||||||||||||
| Servicing rights, net | |||||||||||||||||||
| Goodwill and intangible assets, net | |||||||||||||||||||
| Other assets | |||||||||||||||||||
| Total assets | |||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||||||||||||||
| Liabilities | |||||||||||||||||||
| Deposits | |||||||||||||||||||
| Advances from Federal Home Loan Bank and other borrowings | |||||||||||||||||||
| Subordinated debentures payable to trusts, net of unamortized debt issuance costs | |||||||||||||||||||
| Advances by borrowers for taxes and insurance | |||||||||||||||||||
| Accrued expenses and other liabilities | |||||||||||||||||||
| Total liabilities | |||||||||||||||||||
| Stockholders' equity | |||||||||||||||||||
| Preferred stock | |||||||||||||||||||
| Common stock, $.01 par value, 10,000,000 shares authorized, 9,149,803 and 9,137,906 shares issued at March 31, 2016 and June 30, 2015, respectively | |||||||||||||||||||
| Additional paid-in capital | |||||||||||||||||||
| Retained earnings, substantially restricted | |||||||||||||||||||
| Accumulated other comprehensive (loss), net of related deferred tax effect | |||||||||||||||||||
| Less cost of treasury stock, 2,083,455 shares at March 31, 2016 and June 30, 2015 | |||||||||||||||||||
| Total stockholders' equity | |||||||||||||||||||
| Total liabilities and stockholders' equity |
Loading...
